0001062993-22-013175.txt : 20220520 0001062993-22-013175.hdr.sgml : 20220520 20220520173750 ACCESSION NUMBER: 0001062993-22-013175 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220518 FILED AS OF DATE: 20220520 DATE AS OF CHANGE: 20220520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berelowitz Michael CENTRAL INDEX KEY: 0001493383 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 22948955 MAIL ADDRESS: STREET 1: 415 EAST 37TH STREET STREET 2: APT 36C CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Societal CDMO, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 770-534-8239 MAIL ADDRESS: STREET 1: 1 E. UWCHLAN AVE, SUITE 112 CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: Recro Pharma, Inc. DATE OF NAME CHANGE: 20131010 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-05-18 0001588972 Societal CDMO, Inc. SCTL 0001493383 Berelowitz Michael C/O SOCIETAL CDMO, INC. 1 E UWCHLAN AVE, SUITE 112 EXTON PA 19341 1 0 0 0 Common Stock 2022-05-18 4 A 0 87500 A 164046 D Stock Option (right to buy) 0.8 2022-05-18 4 A 0 118182 0.00 A 2032-05-18 Common Stock 118182 118182 D These restricted stock units will vest in full on May 18, 2023, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis. The stock option will vest in full on May 18, 2023, subject to continued service with the Company. /s/ Ryan D. Lake, Attorney-in-Fact 2022-05-20